Avi Srivastava, Ph.D.
-
Assistant Professor, Genome Regulation and Cell Signaling Program, Ellen and Ronald Caplan Cancer Center
Dr. Srivastava is a computational biologist studying how RNA splicing decisions shape cell fate in drug-resistant cancer and dysregulated immunity.
Dr. Srivastava studies how splicing decisions shape cell fate in disease. He started an independent program to build long-read single-cell technologies and computational methods for mapping these decisions and applying them to identify biomarkers of drug-resistant cancer and dysregulated immunity. Earlier in his career, he contributed to widely used computational genomics platforms during his Ph.D. with Rob Patro at Stony Brook (salmon, alevin, alevin-fry) and his postdoctoral fellowship with Rahul Satija at the New York Genome Center and NYU (Seurat, Signac, scCUT&Tag-pro), which together are used by tens of thousands of laboratories.
The Srivastava Laboratory

The Srivastava Laboratory
The Srivastava lab is built on the ideology that the transcript-isoform is the fundamental unit of biology. Through alternative splicing, alternative polyadenylation, and 3′ UTR choice, twenty thousand protein-coding genes produce more than two hundred thousand distinct transcript isoforms, with different localizations, stabilities, and functions. Standard single-cell RNA-seq reads only the 3′ end of each transcript and so capture only a small fraction of this diversity. The splicing decisions hidden in the rest are exactly the ones that go wrong in disease.
The Srivastava Lab builds the technology and computation to read those decisions one cell at a time. Our platform (BenchDrop-seq) and pipeline (Bagpiper) are released as a preprint and open-source codebase. We are applying them to two specific failures of cell fate: drug-tolerant persister states in NRAS-mutant melanoma, and splicing rewiring of immune cell identity in multiple sclerosis (MS) and Epstein-Barr virus (EBV) – driven dysregulation.
The lab works in close collaboration with the melanoma and multiple sclerosis labs at Wistar and contributes to the broader Wistar-Penn-CHOP ecosystem in cancer immunology and viral autoimmune disease.
-
Research Assistant
-
Learn about job opportunities at The Wistar Institute here.
Research
1. Drug-resistant persister cells in NRAS-mutant melanoma
Most cancer cells exposed to targeted therapy die, but a small population survives in a non-genetic, drug-tolerant persister state and seeds eventual relapse. The molecular basis of this state is poorly understood at a critical level of detail: which transcripts are being produced, in which cells, and at what moments during the response to therapy.
Standard single-cell RNA-seq cannot see this because it counts genes, not isoforms. Persister cells may differ from their drug-sensitive neighbors not only in which genes they express, but in which isoform of each gene, with potential consequences for protein localization, stability, and downstream signaling.
Using BenchDrop-seq and Bagpiper, we are mapping isoform-level transcriptional state across drug-tolerant persister populations. The goal is to identify splicing switches that are causal for persistence and therefore druggable.
2. Splicing rewiring in multiple sclerosis and EBV-driven immune dysregulation
Epstein-Barr virus has been firmly linked to multiple sclerosis, but the mechanism by which a near-universal latent infection produces autoimmune disease in a small subset of carriers remains unclear. Splicing dysregulation is increasingly implicated, but standard tools cannot resolve which immune cell populations are splicing-rewired or how those isoform changes connect to the disease state.
In collaboration with the Lieberman Lab, we are applying BenchDrop-seq to immune cell populations from EBV-positive donors with and without MS, with the goal of identifying splicing signatures of dysregulated immune cell fate that gene-level analysis structurally cannot resolve.
3. BenchDrop-seq & Bagpiper: benchtop long-read single-cell genomics and isoform analysis
BenchDrop-seq is a microfluidics-free single-cell platform that combines PIP-seq capture with Oxford Nanopore long-read sequencing on a standard lab bench, requiring no dedicated instrument. Bagpiper is the computational pipeline that turns raw Nanopore reads into a per-cell, per-isoform count matrix. It performs spacer-anchored barcode recovery, junction-aware read assignment, and expectation-maximization-based resolution of multi-mapping reads. Bagpiper makes BenchDrop-seq quantitatively interpretable and is also applicable to long-read single-cell data generated on other platforms. Github: https://github.com/avisrilab/bagpiper
4. Earlier work (training era)
The lab’s leadership contributed to several widely used computational genomics platforms during graduate and postdoctoral training, which continue to be developed and maintained by their original groups:
– salmon, alevin, alevin-fry: bulk and single-cell RNA-seq quantification with explicit uncertainty propagation. Patro Lab, University of Maryland.
– Seurat: integrated multimodal single-cell analysis. Satija Lab, NYGC.
– Signac: single-cell chromatin state analysis. Satija and Stuart Labs.
– scCUT&Tag-pro: simultaneous chromatin modification and surface protein profiling. Satija Lab.
These tools are widely used across the single-cell genomics field.
Srivastava Lab in the News
Selected Publications
BenchDrop-seq: a microfluidics-free platform for benchtop single-cell long-read RNA sequencing
Jamie Bregman, Calen Nichols, Rajeev Ramisetti, Avi Srivastava
BenchDrop-seq: a microfluids-free platform for benchtop single-cell long-read RNA sequencing. Mar. 12, 2026. doi: https://doi.org/10.64898/2026.03.12.706999
Characterizing cellular heterogeneity in chromatin state with scCUT&Tag-pro
Zhang B, Srivastava A, Mimitou E, Stuart T, Raimondi I, Hao Y, Smibert P, Satija R. Characterizing cellular heterogeneity in chromatin state with scCUT&Tag-pro. Nat Biotechnol. 2022 Aug;40(8):1220-1230. doi: 10.1038/s41587-022-01250-0. Epub 2022 Mar 24. PMID: 35332340; PMCID: PMC9378363.
Alevin efficiently estimates accurate gene abundances from dscRNA-seq data
Srivastava A, Malik L, Smith T, Sudbery I, Patro R. Alevin efficiently estimates accurate gene abundances from dscRNA-seq data. Genome Biol. 2019 Mar 27;20(1):65. doi: 10.1186/s13059-019-1670-y. PMID: 30917859; PMCID: PMC6437997.
Alignment and mapping methodology influence transcript abundance estimation
Srivastava A, Malik L, Sarkar H, Zakeri M, Almodaresi F, Soneson C, Love MI, Kingsford C, Patro R. Alignment and mapping methodology influence transcript abundance estimation. Genome Biol. 2020 Sep 7;21(1):239. doi: 10.1186/s13059-020-02151-8. PMID: 32894187; PMCID: PMC7487471.
Dictionary learning for integrative, multimodal and scalable single-cell analysis
Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C, Satija R. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2023 May 25. doi: 10.1038/s41587-023-01767-y. Epub ahead of print. PMID: 37231261.
Alevin-fry unlocks rapid, accurate and memory-frugal quantification of single-cell RNA-seq data
He D, Zakeri M, Sarkar H, Soneson C, Srivastava A, Patro R. Alevin-fry unlocks rapid, accurate and memory-frugal quantification of single-cell RNA-seq data. Nat Methods. 2022 Mar;19(3):316-322. doi: 10.1038/s41592-022-01408-3. Epub 2022 Mar 11. PMID: 35277707; PMCID: PMC8933848.

